15:35-15:45
观看视频
Development and validation of an individualized metabolism-related prognostic model for adult acute myeloid leukemia patients
15:45-15:55
观看视频
Post-remission measurable residual disease predicts outcome and directs the choice of treatment for patients with intermediate-risk acute myeloid leukemia in CR1
15:55-16:05
观看视频
Efficacy of venetoclax combined with decitabine-based treatment for heavily pre-treated relapsed or refractory AML patients in a real-world setting